AXSM · Axsome Therapeutics Inc. Common Stock
View on chartInsiders & Stakes
| Roger Jeffs Chief Executive Officer | ▼ Sell | Open Market | 58,367 Shares held | 6/11/2026 | View profile |
| Nick Pizzie CHIEF FINANCIAL OFFICER | ▼ Sell | Open Market | 42,867 Shares held | 6/9/2026 | View profile |
| Mark Coleman Director | ▼ Sell | Open Market | 30,389 Shares held | 6/10/2026 | View profile |
| Mark E. Saad Director | ▲ Buy | Option Exercise | 11,431 Shares held | 6/8/2026 | View profile |
| Herriot Tabuteau Chief Executive Officer | ▼ Sell | Open Market | 7,229 Shares held | 8/6/2026 | View profile |
| Susan Mahony | ▼ Sell | Open Market | 829 Shares held | 6/10/2026 | View profile |
| Mark L. Jacobson Chief Operating Officer | ▼ Sell | Open Market | 0 Shares held | 9/3/2026 | View profile |
| Ari Maizel Chief Commercial Officer | ▼ Sell | Open Market | 0 Shares held | 4/22/2026 | View profile |
| Murdock Hunter R. General Counsel | ▼ Sell | Open Market | 0 Shares held | 6/23/2025 | View profile |
Transaction History
| Mark L. Jacobson | ▲ Buy | Option Exercise | 10,000 | $130K | 9/3/2026 |
| Mark L. Jacobson | ▼ Sell | Open Market | 10,000 | $2.1M | 9/3/2026 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 4,660 | $23K | 8/6/2026 |
| Herriot Tabuteau | ▼ Sell | Open Market | 4,660 | $997K | 8/6/2026 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 45,004 | $223K | 8/5/2026 |
| Herriot Tabuteau | ▼ Sell | Open Market | 45,004 | $9.5M | 8/5/2026 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 49,666 | $246K | 7/1/2026 |
| Herriot Tabuteau | ▼ Sell | Open Market | 49,666 | $11.9M | 7/1/2026 |
| Roger Jeffs | ▼ Sell | Open Market | 286 | $71K | 6/11/2026 |
| Roger Jeffs | ▼ Sell | Open Market | 286 | $70K | 6/10/2026 |
| Susan Mahony | ▼ Sell | Open Market | 300 | $74K | 6/10/2026 |
| Mark Coleman | ▼ Sell | Open Market | 643 | $160K | 6/10/2026 |
| Susan Mahony | ▼ Sell | Open Market | 300 | $71K | 6/9/2026 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 49,670 | $246K | 6/9/2026 |
| Herriot Tabuteau | ▼ Sell | Open Market | 49,670 | $12.0M | 6/9/2026 |
| Nick Pizzie | ▲ Buy | Option Exercise | 33,000 | $116K | 6/9/2026 |
| Nick Pizzie | ▼ Sell | Open Market | 33,000 | $7.9M | 6/9/2026 |
| Roger Jeffs | ▲ Buy | Option Exercise | 1,429 | — | 6/8/2026 |
| Mark E. Saad | ▲ Buy | Option Exercise | 1,429 | — | 6/8/2026 |
| Susan Mahony | ▲ Buy | Option Exercise | 1,429 | — | 6/8/2026 |
| Mark Coleman | ▲ Buy | Option Exercise | 1,429 | — | 6/8/2026 |
| Mark Coleman | ▼ Sell | Open Market | 5,537 | $1.2M | 6/2/2026 |
| Mark Coleman | ▼ Sell | Open Market | 6,000 | $1.4M | 6/1/2026 |
| Mark Coleman | ▼ Sell | Open Market | 6,000 | $1.4M | 5/29/2026 |
| Mark L. Jacobson | ▲ Buy | Option Exercise | 233 | $3K | 5/5/2026 |
| Mark L. Jacobson | ▼ Sell | Open Market | 233 | $53K | 5/5/2026 |
| Mark L. Jacobson | ▼ Sell | Open Market | 4,517 | $1.0M | 5/4/2026 |
| Mark L. Jacobson | ▲ Buy | Option Exercise | 4,517 | $58K | 5/4/2026 |
| Ari Maizel | ▲ Buy | Option Exercise | 7,500 | $530K | 4/22/2026 |
| Ari Maizel | ▼ Sell | Open Market | 7,500 | $1.4M | 4/22/2026 |
| Mark Coleman | ▼ Sell | Open Market | 25,000 | $4.0M | 2/26/2026 |
| Mark L. Jacobson | ▲ Buy | Option Exercise | 35,378 | $101K | 2/26/2026 |
| Mark L. Jacobson | ▼ Sell | Open Market | 35,378 | $5.7M | 2/26/2026 |
| Mark Coleman | ▲ Buy | Option Exercise | 6,250 | $31K | 2/23/2026 |
| Mark Coleman | ▲ Buy | Option Exercise | 12,485 | $62K | 2/20/2026 |
| Mark Coleman | ▲ Buy | Option Exercise | 5,193 | $42K | 2/10/2026 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 32,410 | $260K | 2/2/2026 |
| Herriot Tabuteau | ▼ Sell | Open Market | 32,410 | $6.0M | 2/2/2026 |
| Nick Pizzie | ▲ Buy | Option Exercise | 12,000 | $42K | 1/22/2026 |
| Nick Pizzie | ▼ Sell | Open Market | 12,000 | $2.3M | 1/22/2026 |
| Ari Maizel | ▲ Buy | Option Exercise | 7,500 | $530K | 1/21/2026 |
| Ari Maizel | ▼ Sell | Open Market | 7,500 | $1.4M | 1/21/2026 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 31,261 | $251K | 1/7/2026 |
| Herriot Tabuteau | ▼ Sell | Open Market | 31,261 | $5.3M | 1/7/2026 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 29,450 | $236K | 1/6/2026 |
| Herriot Tabuteau | ▼ Sell | Open Market | 29,450 | $5.1M | 1/6/2026 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 78,703 | $631K | 1/5/2026 |
| Herriot Tabuteau | ▼ Sell | Open Market | 78,703 | $13.5M | 1/5/2026 |
| Mark E. Saad | ▲ Buy | Option Exercise | 6,231 | $50K | 12/31/2025 |
| Mark E. Saad | ▼ Sell | Open Market | 6,231 | $1.0M | 12/31/2025 |
| Mark E. Saad | ▲ Buy | Option Exercise | 31,346 | $155K | 12/31/2025 |
| Mark E. Saad | ▼ Sell | Open Market | 31,346 | $5.2M | 12/31/2025 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 10,558 | $85K | 12/4/2025 |
| Herriot Tabuteau | ▼ Sell | Open Market | 10,558 | $1.6M | 12/4/2025 |
| Herriot Tabuteau | ▼ Sell | Open Market | 20,163 | $3.0M | 12/3/2025 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 20,163 | $162K | 12/3/2025 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 49,252 | $395K | 12/2/2025 |
| Herriot Tabuteau | ▼ Sell | Open Market | 49,252 | $7.1M | 12/2/2025 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 21,775 | $175K | 11/5/2025 |
| Herriot Tabuteau | ▼ Sell | Open Market | 21,775 | $2.9M | 11/5/2025 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 50,459 | $405K | 11/4/2025 |
| Herriot Tabuteau | ▼ Sell | Open Market | 50,459 | $6.8M | 11/4/2025 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 91,705 | $735K | 11/3/2025 |
| Herriot Tabuteau | ▼ Sell | Open Market | 91,705 | $12.1M | 11/3/2025 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 12,774 | $102K | 10/8/2025 |
| Herriot Tabuteau | ▼ Sell | Open Market | 12,774 | $1.5M | 10/8/2025 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 13,390 | $107K | 10/7/2025 |
| Herriot Tabuteau | ▼ Sell | Open Market | 13,390 | $1.6M | 10/7/2025 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 19,220 | $154K | 10/6/2025 |
| Herriot Tabuteau | ▼ Sell | Open Market | 19,220 | $2.3M | 10/6/2025 |
| Mark L. Jacobson | ▼ Sell | Open Market | 10,000 | $1.2M | 9/22/2025 |
| Mark L. Jacobson | ▲ Buy | Option Exercise | 10,000 | $29K | 9/22/2025 |
| Mark L. Jacobson | ▲ Buy | Option Exercise | 25,000 | $124K | 9/16/2025 |
| Mark L. Jacobson | ▲ Buy | Option Exercise | 15,000 | $73K | 9/16/2025 |
| Mark L. Jacobson | ▼ Sell | Open Market | 5,783 | $672K | 9/16/2025 |
| Mark L. Jacobson | ▼ Sell | Open Market | 40,000 | $4.6M | 9/16/2025 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 19,719 | $158K | 9/16/2025 |
| Herriot Tabuteau | ▼ Sell | Open Market | 19,719 | $2.3M | 9/16/2025 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 15,254 | $122K | 9/15/2025 |
| Herriot Tabuteau | ▼ Sell | Open Market | 15,254 | $1.8M | 9/15/2025 |
| Herriot Tabuteau | ▲ Buy | Option Exercise | 27,907 | $224K | 9/12/2025 |
| Herriot Tabuteau | ▼ Sell | Open Market | 27,907 | $3.3M | 9/12/2025 |
| Mark Coleman | ▲ Buy | Open Market | 800 | $102K | 9/8/2025 |
| Mark Coleman | ▲ Buy | Open Market | 287 | $37K | 9/8/2025 |
| Mark Coleman | ▲ Buy | Open Market | 488 | $62K | 9/8/2025 |
| Mark E. Saad | ▲ Buy | Option Exercise | 9,127 | $82K | 9/5/2025 |
| Mark E. Saad | ▼ Sell | Open Market | 9,127 | $1.1M | 9/5/2025 |
| Roger Jeffs | ▼ Sell | Open Market | 13,464 | $1.7M | 9/2/2025 |
| Roger Jeffs | ▼ Sell | Open Market | 20,000 | $2.4M | 8/29/2025 |
| Roger Jeffs | ▼ Sell | Open Market | 20,000 | $2.4M | 8/28/2025 |
| Roger Jeffs | ▼ Sell | Open Market | 20,000 | $2.4M | 8/27/2025 |
| Roger Jeffs | ▼ Sell | Open Market | 20,000 | $2.4M | 8/26/2025 |
| Roger Jeffs | ▼ Sell | Open Market | 16,694 | $2.0M | 8/22/2025 |
| Murdock Hunter R. | ▲ Buy | Option Exercise | 6,014 | $180K | 6/23/2025 |
| Murdock Hunter R. | ▼ Sell | Open Market | 6,014 | $602K | 6/23/2025 |
| Murdock Hunter R. | ▲ Buy | Option Exercise | 7,500 | $224K | 6/20/2025 |
| Murdock Hunter R. | ▼ Sell | Open Market | 7,500 | $769K | 6/20/2025 |
| Murdock Hunter R. | ▲ Buy | Option Exercise | 7,500 | $224K | 6/18/2025 |
| Murdock Hunter R. | ▼ Sell | Open Market | 7,500 | $757K | 6/18/2025 |
| Murdock Hunter R. | ▲ Buy | Option Exercise | 7,500 | $224K | 6/17/2025 |
| Murdock Hunter R. | ▼ Sell | Open Market | 7,500 | $752K | 6/17/2025 |
| Murdock Hunter R. | ▲ Buy | Option Exercise | 7,500 | $224K | 6/16/2025 |
| Murdock Hunter R. | ▼ Sell | Open Market | 7,500 | $768K | 6/16/2025 |
| Mark L. Jacobson | ▲ Buy | Option Exercise | 25,000 | $201K | 6/9/2025 |
| Mark L. Jacobson | ▼ Sell | Open Market | 25,000 | $2.8M | 6/9/2025 |
| Mark Coleman | ▼ Sell | Open Market | 3,750 | $388K | 5/28/2025 |
| Mark L. Jacobson | ▲ Buy | Option Exercise | 20,000 | $129K | 5/28/2025 |
| Mark L. Jacobson | ▼ Sell | Open Market | 20,000 | $2.1M | 5/28/2025 |
| Mark Coleman | ▼ Sell | Open Market | 3,750 | $396K | 5/27/2025 |
| Mark L. Jacobson | ▲ Buy | Option Exercise | 20,673 | $134K | 5/27/2025 |
| Mark L. Jacobson | ▼ Sell | Open Market | 20,673 | $2.2M | 5/27/2025 |
| Mark Coleman | ▼ Sell | Open Market | 3,000 | $322K | 5/20/2025 |
| Nick Pizzie | ▲ Buy | Option Exercise | 3,000 | $11K | 2/14/2025 |
| Nick Pizzie | ▼ Sell | Open Market | 3,000 | $393K | 2/14/2025 |
| Nick Pizzie | ▲ Buy | Option Exercise | 12,000 | $42K | 2/13/2025 |
| Nick Pizzie | ▼ Sell | Open Market | 12,000 | $1.6M | 2/13/2025 |
| Mark Coleman | ▲ Buy | Option Exercise | 9,127 | $82K | 1/3/2025 |
| Mark Coleman | ▲ Buy | Option Exercise | 33,410 | $198K | 11/19/2024 |
| Mark E. Saad | ▲ Buy | Option Exercise | 11,016 | $40K | 9/11/2024 |
| Mark E. Saad | ▼ Sell | Open Market | 11,016 | $1.0M | 9/11/2024 |
| Mark L. Jacobson | ▲ Buy | Option Exercise | 47,739 | $193K | 8/9/2024 |
| Mark L. Jacobson | ▼ Sell | Open Market | 47,739 | $4.0M | 8/9/2024 |
| Mark L. Jacobson | ▲ Buy | Option Exercise | 13,693 | $18K | 5/29/2024 |
| Mark L. Jacobson | ▼ Sell | Open Market | 7,910 | $588K | 5/29/2024 |
| Mark Coleman | ▼ Sell | Open Market | 5,248 | $394K | 5/29/2024 |
| Mark Coleman | ▼ Sell | Open Market | 5,249 | $395K | 5/28/2024 |
| Mark L. Jacobson | ▲ Buy | Option Exercise | 24,662 | $32K | 4/1/2024 |
| Mark L. Jacobson | ▼ Sell | Open Market | 24,662 | $1.9M | 4/1/2024 |
| Roger Jeffs | ▼ Sell | Open Market | 2,347 | $168K | 3/15/2024 |
| Roger Jeffs | ▲ Buy | Option Exercise | 2,347 | $70K | 3/15/2024 |
| Roger Jeffs | ▲ Buy | Option Exercise | 13,000 | $286K | 3/14/2024 |
| Roger Jeffs | ▼ Sell | Open Market | 13,000 | $906K | 3/14/2024 |
| Roger Jeffs | ▲ Buy | Option Exercise | 16,976 | $433K | 3/14/2024 |
| Roger Jeffs | ▼ Sell | Open Market | 16,976 | $1.2M | 3/14/2024 |
| Mark Coleman | ▲ Buy | Option Exercise | 11,016 | $40K | 9/15/2023 |
| Mark Coleman | ▼ Sell | Open Market | 11,016 | $828K | 9/15/2023 |
| Mark Coleman | ▼ Sell | Open Market | 18,572 | $1.4M | 9/15/2023 |
| Mark Coleman | ▲ Buy | Option Exercise | 17,501 | $23K | 1/3/2023 |
| Mark Coleman | ▲ Buy | Option Exercise | 3,496 | $5K | 3/15/2022 |
| Roger Jeffs | ▲ Buy | Open Market | 3,950 | $147K | 11/19/2021 |
| Nick Pizzie | ▲ Buy | Open Market | 527 | $19K | 11/18/2021 |
| Nick Pizzie | ▲ Buy | Open Market | 141 | $5K | 11/18/2021 |
| Nick Pizzie | ▲ Buy | Open Market | 145 | $5K | 11/18/2021 |
| Nick Pizzie | ▲ Buy | Open Market | 142 | $5K | 11/18/2021 |
| Mark Coleman | ▲ Buy | Open Market | 409 | $14K | 11/18/2021 |
| Mark Coleman | ▲ Buy | Open Market | 1,021 | $36K | 11/18/2021 |
| Mark E. Saad | ▲ Buy | Open Market | 100 | $3K | 11/17/2021 |
| Mark E. Saad | ▲ Buy | Open Market | 3,000 | $104K | 11/17/2021 |
| Mark E. Saad | ▲ Buy | Open Market | 100 | $3K | 11/17/2021 |
| Mark E. Saad | ▲ Buy | Open Market | 100 | $3K | 11/17/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Deutsche Bank cuts Axsome Therapeutics price target to $267
Deutsche Bank maintained its positive stance on Axsome Therapeutics but lowered its price target to $267. This adjustment comes as the stock trades near a key support level, with recent technical signals indicating a rejection at that price point. While other analysts continue to highlight the company's potential, the latest target remains below the current average analyst estimate.
Deutsche Bank cuts Axsome Therapeutics price target to $267. Deutsche Bank maintained its positive stance on Axsome Therapeutics but lowered its price target to $267. This adjustment comes as the stock trades near a key support level, with recent technical signals indicating a rejection at that price point. While other analysts continue to highlight the company's potential, the latest target remains below the current average analyst estimate.